Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation

JAMA Cardiol. 2016 Jun 1;1(3):366-8. doi: 10.1001/jamacardio.2016.0393.

Authors

Ben Freedman¹, Carlos Martinez², Anja Katholing², Stephan Rietbrock²

Affiliations

¹ Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney, Australia2Sydney Medical School, University of Sydney, Sydney, Australia3Department of Cardiology, Concord Repatriation General Hospital and Anzac Research Institute, Sydney.
² Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.

PMID: 27438123
DOI: 10.1001/jamacardio.2016.0393

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anticoagulants / adverse effects*
Atrial Fibrillation / complications*
Atrial Fibrillation / mortality*
Female
Humans
Male
Stroke / chemically induced*
Warfarin / adverse effects*

Substances

Anticoagulants
Warfarin

Grants and funding

U01 HG006379/HG/NHGRI NIH HHS/United States